1. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Issue 5 (September 2019) Authors: Cook, Lawrence J.; Rose, John W.; Alvey, Jessica S.; Jolley, Anna Marie; Kuhn, Renee; Marron, Brie; Pederson, Melissa; Enriquez, Rene; Yearley, Jeff; McKechnie, Stephen; Han, May H.; Tomczak, Anna J.; Levy, Michael; Mealy, Maureen A.; Coleman, Jessica; Bennett, Jeffrey L.; Johnson, Ruth; Barnes-G... Journal: Neurology Issue: Volume 6:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVID-19 in MS: Initial observations from the Pacific Northwest. Issue 5 (September 2020) Authors: Bowen, James D.; Brink, Justine; Brown, Ted R.; Lucassen, Elisabeth B.; Smoot, Kyle; Wundes, Annette; Repovic, Pavle Journal: Neurology Issue: Volume 7:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Issue 3 (10th December 2022) Authors: Okuda, Darin T.; Kantarci, Orhun; Lebrun‐Frénay, Christine; Sormani, Maria Pia; Azevedo, Christina J.; Bovis, Francesca; Hua, Le H.; Amezcua, Lilyana; Mowry, Ellen M.; Hotermans, Christophe; Mendoza, Jason; Walsh, John S.; von Hehn, Christian; Vargas, Wendy S.; Donlon, Stacy; Naismith, Robert T.;... Journal: Annals of neurology Issue: Volume 93:Issue 3(2023) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early first‐line treatment response and subsequent disability worsening in relapsing–remitting multiple sclerosis. (26th December 2021) Authors: Koch, Marcus W.; Mostert, Jop; Repovic, Pavle; Bowen, James D.; Wolinsky, Jerry S.; Lublin, Fred D.; Strijbis, Eva; Cutter, Gary Journal: European journal of neurology Issue: Volume 29:Number 4(2022) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis. Issue 2 (April 2020) Authors: Buckle, Guy; Bandari, Daniel; Greenstein, Jeffrey; Gudesblatt, Mark; Khatri, Bhupendra; Kita, Mariko; Repovic, Pavle; Riser, Emily; Weinstock-Guttman, Bianca; Thrower, Ben; Loring, Sherrill; Riester, Katherine; Everage, Nick; Prada, Claudia; Koulinska, Irene; Mann, Monica Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 6:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study. (26th January 2021) Authors: Naismith, Robert T.; Bermel, Robert A.; Coffey, Christopher S.; Goodman, Andrew D.; Fedler, Janel; Kearney, Marianne; Klawiter, Eric C.; Nakamura, Kunio; Narayanan, Sridar; Goebel, Christopher; Yankey, Jon; Klingner, Elizabeth; Fox, Robert J.; Shinnar, Shlomo; Ontaneda, Daniel; Riley, Claire S.; ... Journal: Neurology Issue: Volume 96:Number 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS. (July 2022) Authors: W Koch, Marcus; Mostert, Jop; Repovic, Pavle; Bowen, James D; Strijbis, Eva; Uitdehaag, Bernard; Cutter, Gary Journal: Multiple sclerosis Issue: Volume 28:Number 8(2022) Page Start: 1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study. (March 2021) Authors: Wundes, Annette; Wray, Sibyl; Gold, Ralf; Singer, Barry A.; Jasinska, Elzbieta; Ziemssen, Tjalf; de Seze, Jerome; Repovic, Pavle; Chen, Hailu; Hanna, Jerome; Messer, Jordan; Miller, Catherine; Naismith, Robert T. Journal: Therapeutic advances in neurological disorders Issue: Volume 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?. (24th January 2021) Authors: Koch, Marcus W.; Mostert, Jop; Repovic, Pavle; Bowen, James D.; Uitdehaag, Bernard; Cutter, Gary Journal: European journal of neurology Issue: Volume 28:Number 6(2021) Page Start: 2115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis. (April 2022) Authors: Koch, Marcus W; Mostert, Jop; Repovic, Pavle; Bowen, James D; Strijbis, Eva; Uitdehaag, Bernard; Cutter, Gary Journal: Multiple sclerosis Issue: Volume 28:Number 4(2022) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗